Skip to main content
logo
Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
34.07
-1.74 (-4.86%)
At close: Sep 9, 2026, 4:00 PM EDT
34.07
0.00 (0.00%)
After-hours: Sep 9, 2026, 4:10 PM EDT

Alto Neuroscience Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,337553114---
Market Cap Growth
1245.44%384.71%----
Enterprise Value
1,117443-52---
Last Close Price
35.8117.804.23---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
5.733.660.75---
P/TBV Ratio
6.223.660.75---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.110.160.110.140.28-
Net Debt / Equity Ratio
-1.00-1.01-1.00-1.02-1.08-0.95
Net Debt / EBITDA Ratio
2.522.322.221.941.332.16
Net Debt / FCF Ratio
3.202.953.062.141.822.59
Quick Ratio
14.6415.5816.8114.718.7615.17
Current Ratio
14.8515.6916.9215.228.8515.30
Return on Equity (ROE)
-49.17%-41.80%-55.19%-67.95%-88.40%-
Return on Assets (ROA)
-26.78%-22.90%-32.46%-34.38%-45.81%-
Return on Capital Employed (ROCE)
-37.20%-38.30%-41.00%-46.70%-64.50%-44.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-6.18%-11.44%-53.85%---
FCF Yield
-5.05%-9.37%-43.39%---
Buyback Yield / Dilution
-31.27%-17.27%-559.39%-8.27%-42.78%-
SEC Filings: 10-K · 10-Q